Announced Mon, 6 Jul · 15:48 IST
AstraZeneca Pharma India announces three senior management changes
Management Changes View source PDF
ASTRAZEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-1.2%1-day move
₹8247.50
prior close
₹8247.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-1.2-1.6-1.6+0.3-1.0-1.3————
Up moveDown movePending
AI summary
AstraZeneca Pharma India announced three senior management changes for August and September 2026. Mr. Mihir Parikh joins as Director of Commercial Excellence, BD and Strategy from August 1. Mr. Vinay Sharma has been promoted to Director of Rare Diseases Business Unit, also from August 1. Mr. Amay Ashok Pandey has been appointed as Director of the Oncology Business Unit from September 1. All three are designated as Senior Management Personnel.
Likely market impact
Routine senior management reshuffle. No direct impact on shareholders or stock price expected.